Viewing Study NCT05016869


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2025-12-25 @ 8:23 PM
Study NCT ID: NCT05016869
Status: UNKNOWN
Last Update Posted: 2022-08-18
First Post: 2021-08-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer
Sponsor: Chinese Academy of Medical Sciences
Organization:

Organization Data

Organization:
Class: UNKNOWN
Study ID: HMPL-013-FLAG-C102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators